Professional Summary

Professional Overview

Sara Hou is an accomplished business leader with extensive experience in the pharmaceutical and biotech industries. As the CEO of TTY Biopharm Company Limited, she is responsible for driving the strategic vision and operational excellence of the organization. With a strong background in oncology, Sara brings a wealth of industry expertise and a proven track record of delivering impactful results.

Experience Summary

Current Role

As the CEO of TTY Biopharm Company Limited since April 2022, Sara is responsible for leading the company's overall business strategy, driving innovation, and ensuring the delivery of high-quality pharmaceutical products. Under her guidance, TTY Biopharm has continued to expand its reach and impact within the Asia-Pacific region, cementing its position as a leading biopharmaceutical player.

Career Progression

Prior to her current role, Sara held several senior leadership positions within the pharmaceutical industry. She served as the Oncology Asia Pacific Regional Head and Oncology General Manager at Novartis, where she was instrumental in driving the company's growth and market share in the oncology segment. Her exceptional leadership and strategic vision enabled Novartis to solidify its position as a leading player in the Asia-Pacific oncology market.

In addition to her corporate experience, Sara has also served as a Business Advisor and Supervisor at AHEAD Medicine, where she leveraged her expertise to guide the company's strategic initiatives and support the development of innovative healthcare solutions.

Academic Background

Sara holds a Bachelor's degree in Pharmacy from a renowned university, where she graduated with distinction. Her academic achievements and specialized knowledge in the pharmaceutical field have been instrumental in shaping her successful career.

Areas of Expertise

Sara's areas of expertise include oncology, pharmaceutical operations, strategic planning, business development, and talent management. She has a proven ability to drive organizational growth, foster innovation, and lead high-performing teams to achieve ambitious goals.

Professional Impact

Throughout her career, Sara has made significant contributions to the pharmaceutical industry. She has been recognized for her leadership in driving the development and commercialization of innovative oncology treatments, which have positively impacted the lives of patients across the Asia-Pacific region.

Conclusion

With her extensive industry experience, strategic vision, and commitment to excellence, Sara Hou is poised to continue making a lasting impact as the CEO of TTY Biopharm Company Limited. Her dedication to driving innovation and delivering high-quality pharmaceutical solutions positions her as a respected leader in the industry.